Morgan Stanley Accolade, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Accolade, Inc. stock. As of the latest transaction made, Morgan Stanley holds 367,145 shares of ACCD stock, worth $2.53 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

367,145

Previous 293,951 24.9%

Holding current value

$2.53 Million

Previous $1.05 Million 34.32%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.4 - $4.42 $248,859 - $323,517	73,194 Added 24.9%	367,145 $1.41 Million
Q2 2024 Oct 17, 2024	SELL	$3.58 - $10.13 $2.07 Million - $5.85 Million	-577,434 Reduced 66.27%	293,951 $1.05 Million
Q2 2024 Aug 14, 2024	SELL	$3.58 - $10.13 $2.07 Million - $5.85 Million	-577,434 Reduced 66.27%	293,951 $1.05 Million
Q1 2024 Oct 17, 2024	BUY	$9.22 - $15.02 $5.32 Million - $8.67 Million	577,434 Added 196.44%	871,385 $9.13 Million
Q1 2024 Aug 16, 2024	BUY	$9.22 - $15.02 $685,387 - $1.12 Million	74,337 Added 9.33%	871,385 $9.13 Million
Q1 2024 May 15, 2024	BUY	$9.22 - $15.02 $685,387 - $1.12 Million	74,337 Added 9.33%	871,385 $9.13 Million
Q4 2023 Aug 16, 2024	BUY	$6.5 - $12.85 $3.27 Million - $6.46 Million	503,097 Added 171.15%	797,048 $9.57 Million
Q4 2023 Feb 13, 2024	BUY	$6.5 - $12.85 $1.16 Million - $2.29 Million	178,055 Added 28.77%	797,048 $9.57 Million
Q3 2023 Nov 15, 2023	BUY	$10.45 - $15.02 $164,075 - $235,829	15,701 Added 2.6%	618,993 $6.55 Million
Q2 2023 Aug 14, 2023	SELL	$10.52 - $16.06 $637,291 - $972,898	-60,579 Reduced 9.13%	603,292 $8.13 Million
Q1 2023 May 15, 2023	BUY	$7.32 - $14.38 $966,891 - $1.9 Million	132,089 Added 24.84%	663,871 $9.55 Million
Q4 2022 Feb 14, 2023	SELL	$7.19 - $13.16 $1.07 Million - $1.96 Million	-149,048 Reduced 21.89%	531,782 $4.14 Million
Q3 2022 Nov 14, 2022	BUY	$0.0 - $12.8 $0 - $44,800	3,500 Added 0.52%	680,830 $7.77 Million
Q2 2022 Oct 27, 2022	BUY	$5.28 - $18.9 $586,982 - $2.1 Million	111,171 Added 19.64%	677,330 $5.01 Million
Q2 2022 Aug 15, 2022	BUY	$5.28 - $18.9 $586,982 - $2.1 Million	111,171 Added 19.64%	677,330 $5.01 Million
Q1 2022 Oct 27, 2022	SELL	$12.92 - $27.18 $1.44 Million - $3.02 Million	-111,171 Reduced 16.41%	566,159 $9.94 Million
Q1 2022 May 13, 2022	BUY	$12.92 - $27.18 $753,248 - $1.58 Million	58,301 Added 11.48%	566,159 $9.94 Million
Q4 2021 Feb 14, 2022	SELL	$21.96 - $42.69 $317,343 - $616,913	-14,451 Reduced 2.77%	507,858 $13.4 Million
Q3 2021 Nov 15, 2021	BUY	$41.3 - $54.56 $21.6 Million - $28.5 Million	522,309 New	522,309 $22 Million

Others Institutions Holding ACCD

# of Institutions

173

Shares Held

67.6M

Call Options Held

181K

Put Options Held

1.66M

View Full List

About Accolade, Inc.

Ticker ACCD
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 71,938,896
Market Cap $496M
Description
Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and cli...

More about ACCD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account